Trial Profile
Phase III Study of ATL-962 in Obese Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Sep 2018
Price :
$35
*
At a glance
- Drugs Cetilistat (Primary)
- Indications Obesity
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Takeda
- 16 Nov 2012 New trial record